Facial Hyperpigmentation After Ferrinject (Ferric Carboxymaltose) Infusion
Yes, persistent facial hyperpigmentation can occur after ferric carboxymaltose (Ferrinject) infusion, though this typically results from extravasation (leakage of iron into surrounding tissue) rather than a systemic effect, and facial involvement would be unusual unless the infusion site was in the upper extremity with tracking or the patient experienced a different mechanism of iron deposition.
Understanding the Mechanism
The hyperpigmentation your patient is experiencing is most likely cutaneous siderosis - iron deposition in the skin that causes persistent brownish discoloration 1. This occurs when:
- Iron extravasates during infusion, depositing directly into cutaneous tissues
- The iron particles become trapped in the dermis, causing permanent or long-lasting pigmentation
- Unlike typical infusion reactions (flushing, myalgias, back pain) that resolve quickly, cutaneous siderosis persists for months to years 2
Important distinction: The FDA label for Ferrinject lists "facial flushing" as a side effect associated with high blood pressure during infusion 3, but this is transient. Persistent hyperpigmentation lasting months suggests actual iron deposition, not a temporary vascular reaction.
Counseling Your Patient
What to Tell Them
Reassure about prognosis but be realistic:
- This is a cosmetic issue, not a systemic health threat - it does not indicate organ damage or ongoing toxicity
- The pigmentation can be permanent or very long-lasting (months to years)
- It is not an allergic reaction and does not preclude future iron therapy if needed (though different administration techniques should be used)
Treatment Options
Q-switched Nd:YAG laser at 532 nm wavelength is the most effective evidence-based treatment 1:
- Requires multiple sessions (typically 4 or more)
- Parameters: 0.6-1.0 J/cm² fluence with 4 mm spot size
- Complete resolution can take up to 2 years from first treatment
- Minimal adverse effects
- This is the only treatment with published evidence for iron-induced hyperpigmentation
Compression therapy may have preventive value if applied immediately post-extravasation 4, but this is not applicable for established pigmentation.
Prevention for Future Infusions
If your patient requires additional iron therapy:
Critical administration precautions 2:
- Ensure secure IV access before starting infusion
- Start infusion slowly and observe for several minutes
- Use proper dilution (100 mL normal saline for FCM)
- Infuse over 20-30 minutes minimum 2
- Monitor the infusion site continuously for any signs of infiltration
- Consider using a different formulation (ferric derisomaltose has similar efficacy with potentially different safety profile) 2
Clinical Pitfalls to Avoid
Don't confuse this with an allergic reaction: True IgE-mediated hypersensitivity presents with wheezing, hypotension, angioedema - not isolated persistent pigmentation 2
Don't dismiss the cosmetic impact: While medically benign, facial pigmentation can significantly affect quality of life and warrants referral to dermatology for laser therapy
Don't assume all hyperpigmentation is from extravasation: Verify the infusion site and timeline - if pigmentation is distant from the IV site or appeared weeks later, consider alternative diagnoses
Document thoroughly: This is a reportable adverse event that should be documented in the medical record and considered for FDA MedWatch reporting
Next Steps
- Refer to dermatology for Q-switched laser evaluation
- Review the infusion record to confirm if extravasation was documented
- Counsel about realistic timeline: Even with treatment, resolution takes many months
- If future iron therapy is needed, consider alternative formulations or routes, and ensure meticulous IV technique with experienced nursing staff
The evidence strongly supports that while this complication is distressing, it is treatable with specialized laser therapy, though patience is required as resolution is gradual 1.